CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, ...

Are stress and sleepless nights silently damaging your immune system? This powerful new study reveals how anxiety and ...

Stress and broken sleep do not just leave people groggy, they quietly chip away at the very immune cells that keep infections ...

Multiple myeloma is an incurable plasma cell malignancy despite major therapeutic advances. A recent review by Chinese ...

Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing ...

The global natural killer cells therapeutics market size was US$ 2,808.9 million in 2021. The global natural killer cells therapeutics market size is forecast to reach US$ 10,213.5 million by 2030, ...

A research collaboration between MIT and Stanford has developed a new approach intended to help the immune system recognise and attack tumours more effectively. Instead of focusing only on protein ...

Multiple myeloma (MM) is the second most common hematologic malignancy, characterized by the uncontrolled growth of plasma cells and progressive ...

Caribou plans a pivotal Phase 3 randomized trial evaluating approximately 250 patients in second-line large B-cell lymphoma. The FDA granted vispa-cel Regenerative Medicine Advanced Therapy, Orphan ...

Satyen K. Bordoloi My first memory of cancer is the younger brother of a classmate. Blood cancer, we whispered between ...

A study by researchers at the Technion finds that injecting cancerous serum in mice decreased cardiac fibrosis, paving the ...

Chronic fatigue syndrome was once dismissed as an imagined condition, but after years of research, doctors and clinicians ...